Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin-Reference-Cited by-同舟云学术

Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin

Published:1992-05 Issue:1 Volume:107 Page:30-38
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Freo Ulderico,Holloway Harold W.,Greig Nigel H.,Soncrant Timothy T.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF02244962.pdf

Reference52 articles.

1. Anderson JL (1983) Serotonin receptor changes after chronic antidepressant treatments: ligand binding, electrophysiological and behavioral studies. Life Sci 32:1791–1801

2. Aulakh C, Cohen R, Hill JL, Murphy DL, Zohar J (1987) Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats. Br J Pharmacol 91:747–752

3. Aulakh CS, Zohar J, Wozniak KM, Hill JL, Murphy DL (1989) Long-term lithium treatment in rats attenuates m-chlorophenyl-piperazine-induced decreases in food intake but not locomotor activity. Psychopharmacology 98:448–452

4. Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664–2669

5. Caccia S, Ballabio M, Samanin R, Zanini MG, Garattini S (1981) 1-m-chlorophenyl-piperazine, a serotonin agonist, is a metabolite of trazodone. J Pharm Pharmacol 33:477–478

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies on the role of 5-HT2C receptors in the mechanisms of action of antidepressant drugs;Neuroscience & Biobehavioral Reviews;2014-05

2. Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents;Psychopharmacology;2007-02-13

3. Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats;Brain Research;2004-06

4. Monoamine Oxidase and Head-Twitch Response in Mice Mechanisms of α-Methylated Substrate Derivatives;NeuroToxicology;2004-01

5. Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia;Psychopharmacology;2003-04-11